Chimerix Inc (CMRX)
0.90
-0.01
(-1.50%)
USD |
NASDAQ |
Nov 22, 16:00
0.9068
+0.01
(+0.76%)
After-Hours: 20:00
Chimerix Cash from Operations (Quarterly): -20.51M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -20.51M |
June 30, 2024 | -17.68M |
March 31, 2024 | -17.52M |
December 31, 2023 | -14.59M |
September 30, 2023 | -17.93M |
June 30, 2023 | -14.34M |
March 31, 2023 | -22.22M |
December 31, 2022 | -19.99M |
September 30, 2022 | 7.128M |
June 30, 2022 | -10.56M |
March 31, 2022 | -23.45M |
December 31, 2021 | -34.02M |
September 30, 2021 | -15.29M |
June 30, 2021 | -12.72M |
March 31, 2021 | -37.90M |
December 31, 2020 | -9.045M |
September 30, 2020 | -8.299M |
June 30, 2020 | -7.874M |
March 31, 2020 | -10.82M |
December 31, 2019 | -3.469M |
September 30, 2019 | -42.16M |
June 30, 2019 | -13.82M |
March 31, 2019 | -15.73M |
December 31, 2018 | -8.30M |
September 30, 2018 | -12.88M |
Date | Value |
---|---|
June 30, 2018 | -14.04M |
March 31, 2018 | -18.51M |
December 31, 2017 | -12.12M |
September 30, 2017 | -11.38M |
June 30, 2017 | -13.00M |
March 31, 2017 | -13.62M |
December 31, 2016 | -9.697M |
September 30, 2016 | -12.93M |
June 30, 2016 | -12.55M |
March 31, 2016 | -28.64M |
December 31, 2015 | -32.92M |
September 30, 2015 | -24.93M |
June 30, 2015 | -23.02M |
March 31, 2015 | -18.84M |
December 31, 2014 | -16.87M |
September 30, 2014 | -11.45M |
June 30, 2014 | -9.637M |
March 31, 2014 | -9.116M |
December 31, 2013 | -6.785M |
September 30, 2013 | -5.144M |
June 30, 2013 | -7.585M |
March 31, 2013 | -6.045M |
December 31, 2012 | -4.649M |
September 30, 2012 | 12.36M |
June 30, 2012 | -4.68M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-37.90M
Minimum
Mar 2021
7.128M
Maximum
Sep 2022
-15.56M
Average
-14.94M
Median
Cash from Operations (Quarterly) Benchmarks
Abbott Laboratories | 2.705B |
Emergent BioSolutions Inc | 153.70M |
SIGA Technologies Inc | -7.384M |
Tonix Pharmaceuticals Holding Corp | -18.80M |
Geovax Labs Inc | -9.297M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 28.32M |
Cash from Financing (Quarterly) | 0.178M |
Free Cash Flow | -70.42M |
Free Cash Flow Per Share (Quarterly) | -0.2289 |
Free Cash Flow to Equity (Quarterly) | -20.53M |
Free Cash Flow Yield | -87.55% |